SHAREHOLDER ALERT: Law Firm Pomerantz Reminds Shareholders Who Have Suffered Losses on Their Investment in Akebia Therapeutics, Inc. of Class Action and Upcoming Deadline – AKBA |
NEW YORK, March 17, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Akebia...